Sperm banking and the cancer patient
- PMID: 21789080
- PMCID: PMC3126065
- DOI: 10.1177/1756287210368279
Sperm banking and the cancer patient
Abstract
The current concepts, recommendations, and principles of sperm banking as it pertains to the comprehensive care of young men of reproductive age with cancer are reviewed. Obstacles to sperm banking are addressed as well as future directions for fertility-preserving technologies. All cancer therapies-chemotherapy, radiation, and surgery-are potential threats to a man's reproductive potential. In addition, cancer itself can impair spermatogenesis. Thus, sperm cryopreservation prior to initiating life-saving cancer treatment offers men and their families the best chance to father biologically related children and should be offered to all men with cancer before treatment. Better patient and provider education, as well as deliberate, coordinated strategies at comprehensive cancer care centers are necessary to make fertility preservation for male cancer patients a priority during pretreatment planning.
Keywords: assisted reproductive techniques; cryopreservation; male infertility; neoplasms; semen; semen preservation; sperm banks; spermatozoa.
References
-
- Agarwal A. (2000) Semen banking in patients with cancer: 20-year experience. Int J Androl 23(Suppl 2): 16–19 - PubMed
-
- Agarwal A., Allamaneni S.S. (2005) Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr 34: 9–12 - PubMed
-
- Agarwal A., Ranganathan P., Kattal N., Pasqualotto F., Hallak J., Khayal S., et al. (2004) Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril 81: 342–348 - PubMed
-
- Anserini P., Chiodi S., Spinelli S., Costa M., Conte N., Copello F., et al. (2002) Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant 30: 447–451 - PubMed
-
- Apperley J.F., Reddy N. (1995) Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev 9: 93–116 - PubMed
LinkOut - more resources
Full Text Sources
